Siren, L.L.C. Glycomimetics Inc Transaction History
Siren, L.L.C.
- $2 Trillion
- Q3 2024
A detailed history of Siren, L.L.C. transactions in Glycomimetics Inc stock. As of the latest transaction made, Siren, L.L.C. holds 1,965,114 shares of GLYC stock, worth $766,394. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,965,114Holding current value
$766,394% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding GLYC
# of Institutions
39Shares Held
18.7MCall Options Held
1.87MPut Options Held
153K-
Bvf Inc San Francisco, CA9.54MShares$3.72 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$1.04 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY804KShares$313,6930.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny781KShares$304,6290.0% of portfolio
-
Black Rock Inc. New York, NY723KShares$282,0410.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $20.4M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...